PRESS DIGEST- Financial Times - April 26
April 26 The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.
Dec 13 Proteon Therapeutics Inc
* Secondary and tertiary endpoint data and enrollment in second phase 3 ongoing
* Trial did not meet primary efficacy endpoint
* Announces top-line data from phase 3 patency-1 clinical trial of investigational vonapanitase in patients with CKD Source text for Eikon: Further company coverage: (Bangalore.email@example.com)
* Arranged for non-brokered private placement of 1.8 million units of company at a price of $0.30 per Source text for Eikon: Further company coverage: